Atlas Trials

Observational Post-Authorisation Safety Study of Asenapine (Sycrest)

Clinical trial NCT01734278 · COMPLETED

Trial details

NCT number
NCT01734278
Sponsor
Professor Saad Shakir
Status
COMPLETED
Study type
OBSERVATIONAL
Manic Disorder
Start date
2012-10-01
Primary completion
2017-01-01
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.